BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)
April 28, 2025 04:00 ET | Source: BlackfinBio CHESHIRE, United Kingdom, April…
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care…
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care…
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care…
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care…
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care…
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care…